To address the role of MTHFR expression as a moderator of smoking's effect on cg05575921, as well as to add controls for potential secondhand smoke exposure, we examined a sample of young adults from the Am J Med Genet. 2018;177B:529-534.
MTHFR regulatory effects on methylation of CG05575921 in response to smoking: Effects are also discernable using MTHFR expression To the Editor:
In this letter, we present novel research replicating and extending recently reported findings by Beach et al. (2017a) using a new sample of young adult African Americans and a focus on methylene tetrahydrofolate reductase (MTHFR) expression to show generalization across a different method of indexing MTHFR availability. Beach et al. (2017a) suggested that, because MTHFR is the rate-limiting enzyme in the methyl cycle, a pathway critical for folate availability, it is potentially a source of individual differences in efficiency of methylation repair activities (Stover, 2009) , and so degree of demethylation at cg05575921 in response to smoking. Reduced MTHFR availability, whether indexed via greater methylation or lower gene expression, should enhance demethylation in response to smoking. Conversely, greater MTHFR availability, whether indexed by lower methylation or greater gene expression, should blunt the impact of smoking on demethylation of cg05575921. Providing initial support for this hypothesis, Beach et al. (2017a) showed that level of methylation of MTHFR (i.e., mMTHFR) moderated the impact of smoking on CG05575921 demethylation in two independent samples (N 5 293; N 5 368) of African American young adults. Those with greater mMTHFR showed greater demethylation at cgCG05575921 in response to smoking.
Level of demethylation of CG05575921 in response to smoking is of particular interest because it captures a key element in the biological regulation of the response to smoking. In brief, change in methylation status at cg05575921 in response to smoking is directly related to the role of AHRR, the gene on which cg05575921 is located, in response to the dioxin and poly aromatic hydrocarbons found in tobacco smoke (Talhout et al., 2011) . The initial response to these toxins is a robust cellular response that includes activation of the aryl hydrocarbon receptor (AHR), and in turn, activation of CYP1A1, CYP1A2, and CYP1B1. However, because the unrestrained activity of the xenobiotic response system is potentially dangerous, and so under tight regulatory control, a second nuclear receptor, AHRR, serves as a feedback modulator of the effects of AHR activation, competing for the obligate heterodimer partner of AHR, the aryl hydrocarbon nuclear translocator, and for DNA binding motifs for AHR. The enhancer region of AHRR that includes cg05575921 plays a key role in increased AHRR transcription (Zeilinger et al., 2013) .
Notwithstanding the clear importance of demethylation at cg05575921 in the response to smoking, several potential concerns can be raised regarding the generalizability of the moderating role of MTHFR availability reported by Beach et al. (2017a) . In particular, the initial report focused on mMTHFR to index MTHFR availability. Although the authors suggested that mMTHFR may influence MTHFR availability via effects on MTHFR expression, they did not directly examine MTHFR expression as a moderator of smoking's effects. If Beach et al. (2017a) account of MTHFR's role in regulating demethylation at cg05575921 in response to smoking is correct, however, individual differences in level of MTHFR expression should provide an alternative approach to index MTHFR availability, and so should also moderate smoking's effect on cg05575921. Gene expression, in general, would be expected to show a similar, but reversed, pattern compared to that seen using MTHFR methylation. That is, lower levels of MTHFR expression, should predict greater demethylation at cg05575921 in response to smoking. Conversely, greater MTHFR expression should predict a blunted impact of smoking on demethylation of cg05575921. Accordingly, using a new young adult sample of similar racial composition (African American), sample size (n 5 334), and sex balance (N 5 117 males; N 5 217 females), we conducted a stringent conceptual replication, examining the moderating effect of MTHFR expression on the extent to which self-reported smoking resulted in demethylation at cg05575921. As we did for the prior analyses, we also present analyses including only cotinine verified nonsmokers, thereby replicating findings in a subsample that excludes probable under reporters of smoking.
In addition to potential concerns regarding lack of direct examination of MTHFR expression as an index of MTHFR availability, there also are potential concerns regarding lack of controls for the possible impact of secondhand smoke exposure or family history of smoking on methylation in general, and demethylation at cg05575921 in particular.
Levels of cotinine are elevated in passive smokers, and so gene expression may also be sensitive to secondhand smoke (Benowitz, Hukkanen, & Jacob, 2009) , suggesting the value of controlling secondhand smoke effects or other smoking-related family effects that may influence demethylation of cg05575921. Controlling for these effects may qualify or eliminate apparent moderating effects of MTHFR availability.
family and community health study (FACH) , an ongoing project focused on risk and protective factors for the health of young-adult African Americans who, along with a parent figure, have been followed since childhood. The sample had a mean age of 29 at the time of their blood draw. Details on prior waves of data collection for the FACH project, general procedures utilized, and sample characteristics are described in prior publications (Beach et al., 2017b; Simons et al., in press ). Selfreported smoking status at prior waves were used to establish smoking history across an 8-year period. Specifically, to assess Cigarette smoking across three waves of data collection from ages 21 to 29 young adults were asked "In the past month, how much did you smoke cigarettes?" Response options included: 0, none at all; 1, up to one cigarette a day; 2, 2 or 3 cigarettes a day; 3, up to a pack a day; 4, More than a pack a day. Then, scores were summed across waves. To establish robustness of effects, supplemental analyses examined effects using a dichotomous measure of smoking. For the supplemental analyses, anyone who indicated any smoking in the past 3 months at any of the three assessment waves from age 21 to 29 was classified as a "smoker." Those who answered "no" at all waves were classified as "non-smokers."
| B LOOD -BA SED M E ASUR E S
A certified phlebotomist drew several tubes of blood at each participant's home, two of which are germane to the current investigation. To examine mRNA, we used PAXgene tubes that were spun and then stored in a 2808 freezer until use. DNA for the droplet digital PCR used whole blood and was prepared according to previously published protocols (Philibert, Beach, & Brody, 2012; Philibert, Beach, Lei, & Brody, 2013) . Additional samples of blood were collected for other purposes as well as for storage for future use.
All participants who provided blood at the final wave of assessment at mean age 29.11 (SD 5 0.74) were eligible for inclusion.
| G EN OM EWI D E mR NA
All available samples were sent to the Rutgers repository. After excluding samples with poor quality (n 5 81) and samples with no amplification (n 5 3), we were left with a total sample of N 5 368 young adults with mRNA, of whom 334 also had all self-report report measures and CG05575921 methylation values. The viable samples were annotated using the Illumina HumanHT-12 v4 BeadChip where 200 ng of total RNA was processed according to the protocol supplied by Illumina. All samples were randomized prior to array hybridization using either two or three technical replicates. After background subtraction, raw illumina probe data were exported from GenomeStudio software (version 1.1.1). The microarray data set of 47,323 probes was filtered by removing probes with detection threshold of p .05, and probes with fewer than three beads present were also excluded, leaving 44,846 probes for analysis. Then, robust multiarray average normalized data was log 2 transformed after quantile normalization and the quality of the microarray images was inspected visually using the ArrayAnalysis quality control pipeline (www.arrayanalysis.org). The results showed that there were no significant batch effects after quantile normalization. Finally, MTHFR gene expression was characterized as the value of the target transcript (ILMN_1734830) located in 1p36.22.
The Illumina HumanHT-12 V4 BeadChip provides coverage for 31,000 annotated genes with more than 47,000 probes derived from the National Center for Biotechnology Information Reference Sequence (RefSeq) release. It has been validated against TaqMan qRT-PCR, and RNA-seq, as well as other microarray platforms and shows good reliability with these alternative assessment methods for high expression transcripts such as MTHFR (Yu et al., 2015) . In the current sample, MTHFR expression was in the 84th percentile of all mRNA transcripts assessed. methylation array data using qPCR has been previously published (Dogan et al., 2014) and ddPCR at CG05575921 has been successfully used to quantify reversion of smoking (Philibert et al., 2015) . The reliability of the ddPCR method to quantify cg05575921 methylation was also examined by Andersen, Philibert, Gibbons, Simons, and Long (2017) , showing that this approach is reliably associated with smoking status, as confirmed by serum cotinine. In addition, a direct comparison of Epic methylation array assessment of cg05575921 to ddPCR assessment, along with establishment of a normal range with 400 adult subjects is in preparation (Philibert et al., Manuscript in preparation), again showing good correspondence (r 5 .991) across methods.
| SEC OND H A ND SM OKE EXP OSUR E
Potential concurrent secondhand smoke exposure or other family influences from parents was controlled by using target report of parent's smoking at the time of the blood draw (i.e., did parent(s) use tobacco during the past 12 months?) and secondhand smoke from friends was controlled using report of friend smoking (e.g., during the past 12 months, how many of your closest friends have used cigarettes?) as covariates.
| CH A RA CTE R IZ AT ION OF C EL L T YP E V AR I A TI ON
Using a method developed by Cole et al. (2015) , we also controlled for individual variation in the relative prevalence of five major cell types.
Estimates were derived using relative abundance of gene transcripts encoding canonical markers of monocytes (CD14), natural killer cells (CD16/FCGR3A, CD56/NCAM1), CD41 and CD81 T-lymphocyte subsets (CD3D, CD3E, CD4, CD8A), and B lymphocytes (CD19).
| A N A LY TI C P L AN
We used Beta regressions, as we have done previously (Beach et al., 2017a) . Because the dependent variable (degree of methylation in CG05575921) is calculated as a ratio of methylated to unmethylated loci ranging from zero to one, it typically fails the assumption of having a normal distribution (Dolzhenko & Smith, 2014) . Beta regressions, utilizing the beta distribution, were introduced by (Ferrari & Cribari-Neto, 2004) , to handle dependent variables that are bounded in this manner, accommodating the non-normal distribution that is introduced as a consequence.
| P OWE R
Using the G*Power program we examined whether the current sample had sufficient power to reliably detect the main effect of smoking and the moderating effect of MTHFR expression and smoking on CG05575921 with 334 participants. The program indicated a statistical power greater than 80% at a 5 0.05 for the model used in our regression analysis presented below (effect size of the main effect 5 0.163; effect size of the interaction effect 5 0.027).
| RE S U L TS
As can be seen in Table 1 , on step 1 of the beta regression, we entered the main effect of cumulative self-reported smoking across seven years in early adulthood (i.e., waves 5, 6, and 7; ages 21-29). We examined the impact of self-reported smoking in a multivariate context, controlling for the effect of sex, cell-type variation, and effects of secondhand smoke exposure via primary care givers and best friends in all analyses.
Replicating prior results, there was a robust effect of smoking which was inversely associated with CG05575921, as were reports of potential secondhand smoke exposure. Indices of cell-type variation were not significantly associated with CG05575921. Further replicating and extending the previously reported finding by Beach et al. (2017a) , in model 3, it can be seen that MTHFR expression (i.e., level of MTHFR mRNA) moderated smoking's effect on demethylation of CG05575921.
The moderating effect of level of MTHFR expression is explicated in Figure 1 . It can be seen that lower gene expression at MTHFR was associated with a steeper slope relating smoking to CG05575921 whereas greater gene expression was associated with a blunted effect of smoking on CG05575921. That is, the hypothesized pattern of effect was found, reversing that seen previously for mMTHFR.
To provide a more stringent test, moderating effects were also examined after excluding those who reported no smoking but had Beta regression models depicting moderating effects of variation in MTHFR expression on cg05575921 in response to smoking. Interaction explicated in Figure 1 . Notes. MTHFR 5 ILMN_1734830; unstandardized coefficients (b) and odds ratio (e b ) shown with standard errors in parentheses. n 5 334. † p .10. *p .05. **p .01 (two-tailed tests).
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elevated cotinine levels at the time of their blood draw, raising questions regarding the accuracy of their self-reported smoking abstinence. As can be seen in Table 2 , all significant effects replicated in the cotinine verified subsample, except that secondhand smoking effects via friends was no longer a significant predictor of CG05575921. In addition, the significant interaction effect remained significant and in the same direction as for the full sample. Table 2 . Effects of cigarette use at ages 21-29 on cg05575921 moderated by variation in MTHFR expression (n 5 334) using all available participants TABLE 2 Beta regression models depicting moderating effects of variation in MTHFR expression on cg05575921 in response to smoking, excluding (n 5 64) individuals who self-reported no cigarette use past 8 years, but had cotinine value >1 In supplemental analyses, we examined the robustness of MTHFR moderating effects by replicating all analyses using a dichotomous measure of smoking rather than the quantity measure of smoking reported above. In all cases, the effects were exactly replicated. See Supporting Information Table S1 for results with the full sample, Supporting Information Table S2 for results with the cotinine verified subsample, and Supporting Information Figure S1 .
FIG URE 1 Explication of significant interaction effect in

0 | CON CL U S I ONS
Supporting and extending the prior report that MTHFR plays a potentially important regulatory role on demethylation in response to smoking (Beach et al., 2017a) , we found evidence of regulatory effects of MTHFR using Accordingly, it will be important to examine the impact of MTHFR expression, as well as methylation of MTHFR, to see if they have the effect of exaggerating hypermethylation for those loci known to show hypermethylation in response to smoking, or if they predict less hypermethylation.
For practical applications, current results suggest the presence of important sources of individual variability in response to the demethylating effects of smoking at CG05575921, suggesting that when accurate quantification of prior smoking exposure is a goal, it may be useful to correct for the moderating influence of MTHFR expression.
Some limitations of the current analyses should also be noted. In particular, given the centrality of the folate cycle to a broad range of biological activities, it is possible that MTHFR expression may be correlated with broader patterns of gene expression that would be informative. Future examination of genomewide patterns in larger samples is therefore indicated. Nonetheless, the current letter is potentially useful in providing additional support for the hypothesis that MTHFR expression may be an important regulatory motif with a role in regulating response to smoking, perhaps furthering efforts to understand the mechanisms that render smoking the single greatest preventable cause of morbidity and mortality in the United States (Centers for Disease Control and Prevention, 2008) .
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